Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Feb;65(2):645–650. doi: 10.1128/iai.65.2.645-650.1997

Selection of Opa+ Neisseria gonorrhoeae by limited availability of normal human serum.

M P Bos 1, D Hogan 1, R J Belland 1
PMCID: PMC176109  PMID: 9009326

Abstract

Experimental infections of human male volunteers with Neisseria gonorrhoeae have provided valuable insights into the early stages of gonorrheal disease. Bacterial variants expressing outer membrane opacity (Opa) proteins appear to be selected from the inoculum during a period in which total recoverable numbers of bacteria decrease rapidly. This apparent survival advantage occurs simultaneously with the onset of an inflammatory response, characterized by local production of interleukin 6 (IL-6) and IL-8 and the appearance of leukocytes in urine. Since the inflammatory response may also result in the presence of serum factors on the mucosal surface, we investigated the possibility that killing in normal human serum (NHS) leads to the selection of Opa+ variants. We therefore studied killing of separate populations and mixtures of Opa- and Opa+ N. gonorrhoeae MS11mk in NHS. Expression of an Opa protein conferred a survival advantage upon the organism; i.e., the Opa+ variants were more serum resistant than their isogenic Opa- counterparts, resulting in a selection for Opa+ phenotypes when a mixture of Opa+ and Opa- gonococci (GC) was exposed to submaximal doses of NHS. This selection was observed in three different lipooligosaccharide (LOS) backgrounds, indicating that it was not due to a difference in LOS expression between Opa- and Opa+ phenotypes. Incubation in NHS of sialylated GC resulted in a similar selection for Opa+ variants. The presence of normal human urine during the serum killing assay had no effect on the selection phenomenon but drastically depleted NHS of bactericidal activity, which was found to be at least partly due to complement inhibition. The results suggest that serum killing may contribute to the transition from Opa- to Opa+ phenotypes during the early stages of infection of the male urethra.

Full Text

The Full Text of this article is available as a PDF (222.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chen T., Swanson J., Wilson J., Belland R. J. Heparin protects Opa+ Neisseria gonorrhoeae from the bactericidal action of normal human serum. Infect Immun. 1995 May;63(5):1790–1795. doi: 10.1128/iai.63.5.1790-1795.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Clifton V. L., Husband A. J., Kay D. J. Local immunity in the male reproductive tract. Immunol Cell Biol. 1992 Oct;70(Pt 5):301–307. doi: 10.1038/icb.1992.38. [DOI] [PubMed] [Google Scholar]
  3. Frangipane J. V., Rest R. F. Anaerobic growth and cytidine 5'-monophospho-N-acetylneuraminic acid act synergistically to induce high-level serum resistance in Neisseria gonorrhoeae. Infect Immun. 1993 May;61(5):1657–1666. doi: 10.1128/iai.61.5.1657-1666.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Griffiss J. M., Jarvis G. A., O'Brien J. P., Eads M. M., Schneider H. Lysis of Neisseria gonorrhoeae initiated by binding of normal human IgM to a hexosamine-containing lipooligosaccharide epitope(s) is augmented by strain-specific, properdin-binding-dependent alternative complement pathway activation. J Immunol. 1991 Jul 1;147(1):298–305. [PubMed] [Google Scholar]
  5. James J. F., Zurlinden E., Lammel C. J., Brooks G. F. Relation of protein I and colony opacity to serum killing of Neisseria gonorrhoeae. J Infect Dis. 1982 Jan;145(1):37–44. doi: 10.1093/infdis/145.1.37. [DOI] [PubMed] [Google Scholar]
  6. Jerse A. E., Cohen M. S., Drown P. M., Whicker L. G., Isbey S. F., Seifert H. S., Cannon J. G. Multiple gonococcal opacity proteins are expressed during experimental urethral infection in the male. J Exp Med. 1994 Mar 1;179(3):911–920. doi: 10.1084/jem.179.3.911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Joiner K. A. Complement evasion by bacteria and parasites. Annu Rev Microbiol. 1988;42:201–230. doi: 10.1146/annurev.mi.42.100188.001221. [DOI] [PubMed] [Google Scholar]
  8. Joiner K. A., Scales R., Warren K. A., Frank M. M., Rice P. A. Mechanism of action of blocking immunoglobulin G for Neisseria gonorrhoeae. J Clin Invest. 1985 Nov;76(5):1765–1772. doi: 10.1172/JCI112167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Joiner K. A., Warren K. A., Brown E. J., Swanson J., Frank M. M. Studies on the mechanism of bacterial resistance to complement-mediated killing. IV. C5b-9 forms high molecular weight complexes with bacterial outer membrane constituents on serum-resistant but not on serum-sensitive Neisseria gonorrhoeae. J Immunol. 1983 Sep;131(3):1443–1451. [PubMed] [Google Scholar]
  10. Lesse A. J., Campagnari A. A., Bittner W. E., Apicella M. A. Increased resolution of lipopolysaccharides and lipooligosaccharides utilizing tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J Immunol Methods. 1990 Jan 24;126(1):109–117. doi: 10.1016/0022-1759(90)90018-q. [DOI] [PubMed] [Google Scholar]
  11. Mandrell R. E., Lesse A. J., Sugai J. V., Shero M., Griffiss J. M., Cole J. A., Parsons N. J., Smith H., Morse S. A., Apicella M. A. In vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation. J Exp Med. 1990 May 1;171(5):1649–1664. doi: 10.1084/jem.171.5.1649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. McCutchan J. A., Wunderlich A., Braude A. I. Role of urinary solutes in natural immunity to gonorrhea. Infect Immun. 1977 Jan;15(1):149–155. doi: 10.1128/iai.15.1.149-155.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Noble R. C., Parekh M. C. Bactericidal properties of urine for Neisseria gonorrhoeae. Sex Transm Dis. 1987 Oct-Dec;14(4):221–226. doi: 10.1097/00007435-198710000-00009. [DOI] [PubMed] [Google Scholar]
  14. Parsons N. J., Andrade J. R., Patel P. V., Cole J. A., Smith H. Sialylation of lipopolysaccharide and loss of absorption of bactericidal antibody during conversion of gonococci to serum resistance by cytidine 5'-monophospho-N-acetyl neuraminic acid. Microb Pathog. 1989 Jul;7(1):63–72. doi: 10.1016/0882-4010(89)90112-5. [DOI] [PubMed] [Google Scholar]
  15. Persson C. G., Erjefält I., Alkner U., Baumgarten C., Greiff L., Gustafsson B., Luts A., Pipkorn U., Sundler F., Svensson C. Plasma exudation as a first line respiratory mucosal defence. Clin Exp Allergy. 1991 Jan;21(1):17–24. doi: 10.1111/j.1365-2222.1991.tb00799.x. [DOI] [PubMed] [Google Scholar]
  16. Pettit R. K., Judd R. C. Characterization of naturally elaborated blebs from serum-susceptible and serum-resistant strains of Neisseria gonorrhoeae. Mol Microbiol. 1992 Mar;6(6):723–728. doi: 10.1111/j.1365-2958.1992.tb01521.x. [DOI] [PubMed] [Google Scholar]
  17. Price R. J., Boettcher B. The presence of complement in human cervical mucus and its possible relevance to infertility in women with complement-dependent sperm-immobilizing antibodies. Fertil Steril. 1979 Jul;32(1):61–66. doi: 10.1016/s0015-0282(16)44117-8. [DOI] [PubMed] [Google Scholar]
  18. Ramsey K. H., Schneider H., Cross A. S., Boslego J. W., Hoover D. L., Staley T. L., Kuschner R. A., Deal C. D. Inflammatory cytokines produced in response to experimental human gonorrhea. J Infect Dis. 1995 Jul;172(1):186–191. doi: 10.1093/infdis/172.1.186. [DOI] [PubMed] [Google Scholar]
  19. Rice P. A. Molecular basis for serum resistance in Neisseria gonorrhoeae. Clin Microbiol Rev. 1989 Apr;2 (Suppl):S112–S117. doi: 10.1128/cmr.2.suppl.s112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Schneider H., Griffiss J. M., Boslego J. W., Hitchcock P. J., Zahos K. M., Apicella M. A. Expression of paragloboside-like lipooligosaccharides may be a necessary component of gonococcal pathogenesis in men. J Exp Med. 1991 Dec 1;174(6):1601–1605. doi: 10.1084/jem.174.6.1601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Schneider H., Griffiss J. M., Mandrell R. E., Jarvis G. A. Elaboration of a 3.6-kilodalton lipooligosaccharide, antibody against which is absent from human sera, is associated with serum resistance of Neisseria gonorrhoeae. Infect Immun. 1985 Dec;50(3):672–677. doi: 10.1128/iai.50.3.672-677.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Smith H., Parsons N. J., Cole J. A. Sialylation of neisserial lipopolysaccharide: a major influence on pathogenicity. Microb Pathog. 1995 Dec;19(6):365–377. doi: 10.1006/mpat.1995.0071. [DOI] [PubMed] [Google Scholar]
  23. Swanson J., Barrera O., Sola J., Boslego J. Expression of outer membrane protein II by gonococci in experimental gonorrhea. J Exp Med. 1988 Dec 1;168(6):2121–2129. doi: 10.1084/jem.168.6.2121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Swanson J. Studies on gonococcus infection. XII. Colony color and opacity varienats of gonococci. Infect Immun. 1978 Jan;19(1):320–331. doi: 10.1128/iai.19.1.320-331.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Taha M. K. Increased sensitivity of gonococcal pilA mutants to bactericidal activity of normal human serum. Infect Immun. 1993 Nov;61(11):4662–4668. doi: 10.1128/iai.61.11.4662-4668.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ward M. E., Watt P. J., Glynn A. A. Gonococci in urethral exudates possess a virulence factor lost on subculture. Nature. 1970 Jul 25;227(5256):382–384. doi: 10.1038/227382a0. [DOI] [PubMed] [Google Scholar]
  27. Wetzler L. M., Barry K., Blake M. S., Gotschlich E. C. Gonococcal lipooligosaccharide sialylation prevents complement-dependent killing by immune sera. Infect Immun. 1992 Jan;60(1):39–43. doi: 10.1128/iai.60.1.39-43.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. de la Paz H., Cooke S. J., Heckels J. E. Effect of sialylation of lipopolysaccharide of Neisseria gonorrhoeae on recognition and complement-mediated killing by monoclonal antibodies directed against different outer-membrane antigens. Microbiology. 1995 Apr;141(Pt 4):913–920. doi: 10.1099/13500872-141-4-913. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES